- Home
- ICLR vs BALL Comparison
ICLR vs BALL Comparison
Compare ICLR & BALL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ICLR | BALL |
|---|---|---|
| Founded | 1990 | 1880 |
| Country | Ireland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Commercial Physical & Biological Resarch | Containers/Packaging |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.3B | 12.8B |
| IPO Year | 1998 | N/A |
Fundamental Metrics
Financial Performance| Metric | ICLR | BALL |
|---|---|---|
| Price | $185.83 | $49.20 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 14 | 13 |
| Target Price | ★ $201.23 | $61.75 |
| AVG Volume (30 Days) | 1.0M | ★ 3.0M |
| Earning Date | 10-22-2025 | 11-04-2025 |
| Dividend Yield | N/A | ★ 1.63% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 7.47 | 2.40 |
| Revenue | $8,102,602,000.00 | ★ $12,694,000,000.00 |
| Revenue This Year | N/A | $11.82 |
| Revenue Next Year | $0.76 | $4.19 |
| P/E Ratio | $24.87 | ★ $19.54 |
| Revenue Growth | N/A | ★ 7.41 |
| 52 Week Low | $125.10 | $43.51 |
| 52 Week High | $228.29 | $60.71 |
Technical Indicators
Market Signals| Indicator | ICLR | BALL |
|---|---|---|
| Relative Strength Index (RSI) | 62.18 | 53.16 |
| Support Level | $174.13 | $48.26 |
| Resistance Level | $191.15 | $50.03 |
| Average True Range (ATR) | 8.46 | 0.89 |
| MACD | 2.87 | 0.10 |
| Stochastic Oscillator | 85.77 | 59.65 |
Price Performance
Historical ComparisonAbout ICLR ICON plc
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.
About BALL Ball Corporation
Ball is the world's largest metal can manufacturer with market share over 30% in its three main regions (North America, Europe, and South America). The company is focused on increasing capacity amid a wave of new developed-market demand, while also investing in faster-growing emerging-market economies. Ball spun-off its glass jar business in 1993 and is now owned by Newell. The company reports three segments—beverage packaging, North and Central America (48% of 2024 revenue), beverage packaging, EMEA (29%), beverage packaging, South America (17%)—and it generated $12 billion in revenue in 2024.